Global Conference on

Vaccines Research and Development

August 26-28, 2021 | Webinar

  • Theme
  • Expanding Present Vaccine Research Outcomes in the wake of Pandemic

Submit Abstract Register Now

Scientific Board

Aim

Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Vaccines Research and Development.

Objective

To provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Vaccines Research and Development.

Dates to remember

Abstract Submission
June 28, 2021
Early Bird Registration
March 15, 2021
Conference Dates
August 26-28, 2021

About Conference

Conference Chair Welcome Message:
 
On behalf of the Organizing Committee, it is our pleasure to welcome all participants to the Global Conference on Vaccines, Vaccines–2021 to be held from August 26–28, 2021.  Vaccines have taken center stage.  The response to the COVID-19 pandemic has seen an unprecedented explosion in R&D, cooperation and collaboration.  We see new ideas, new approaches and new vaccines. The global pace is breathtaking!   We welcome all organizers, experts in the field, delegates, speakers and students. We especially encourage young researchers to present their recent research and to interact with other co-participants.  
 
I look forward to meeting and welcoming you all to Vaccines Conference-2021 via Online Mode.
 

Dr. Daniel R. Henderson
Chair | Vaccines Conference-2021
CEO & CSO - Verndari, Inc.
USA
 
Conference CO-Chair Welcome Message:
 
It is my pleasure to welcome you to this year Vaccines 2021 conference. The past 2 years have redefined our global approach to pandemic preparedness and solution deployement. Vaccines more than any other approaches have been at the center through the innovations and failures that we have witnessed. This has challenged the current approaches to vaccinology at all level, from vaccines platform development and licensure, clinical and licensure, but also open a realm of possibilities for the future of vaccines and vaccination.
 
I look forward to the presentations and discussions, and welcome and encourage young researchers to engage with all during this conference that has the potential to shape their future in this exiting field of sciences.
 

Dr. Nathalie Garcon
CO-Chair | Vaccines Conference-2021
CEO/CSO-BIOASTER
France
 


Guidelines for the Abstract Submission:
1. The acceptable word range for the abstract is 150 – 250 words.
2. The abstracts which do not meet this word limit will be sent back to the author's to be revised.
3. The abstract content should be in English.
4. Please send with brief biography together with the Abstract.
5. Submit your abstract to (vaccines-2021@pagesconferences.com) mail Id.
6. After submission you will be acknowledged with the acceptance letter via an email within 2-3 working days.
 

 

Submit Abstract Register Now

Plenary Speakers

Prof. Dr. S.H.E. Kaufmann
Prof. Dr. S.H.E. Kaufmann

Director-Max Planck Institute for Infection Biology, Germany

Prof. Shan Lu
Prof. Shan Lu

University of Massachusetts Medical School
USA

Prof. Nikolai Petrovsky
Prof. Nikolai Petrovsky

Chairman-Vaxine Pty Ltd
Australia

Dr. Brian W. Tobin
Dr. Brian W. Tobin

Executive Director-Synergy Global Health Foundation, Inc.
USA

Prof. Maria Jose Alonso
Prof. Maria Jose Alonso

Editor-in-Chief- DDTR Journal
Spain

Dr. Sherry Layton
Dr. Sherry Layton

CEO-Vetanco
USA

Prof. Dr. S. Louise Cosby
Prof. Dr. S. Louise Cosby

Head-Virology
Agri-Food and Biosciences Institute
United Kingdom

Dr. Camille Locht
Dr. Camille Locht

Research Director, National Institute of Health and Medical Research
France

Dr. Wieslaw Swietnicki
Dr. Wieslaw Swietnicki

Scientist-Institute of Immunology and Experimental Therapy PAS
Poland

Dr. Sergey Suchkov
Dr. Sergey Suchkov

Sechenov University
Russia

Prof. Yehuda Shoenfeld
Prof. Yehuda Shoenfeld

Head-Zabludowicz Center for Autoimmune Diseases
Israel

Keynote Speakers

Dr. Daniel R. Henderson
Dr. Daniel R. Henderson

CEO & CSO - Verndari, Inc.
USA

Dr. Pirouz Daftarian
Dr. Pirouz Daftarian

Director of Scientific Engagement-CrownBio/MBLI
North California

Dr. Delese Mimi Darko
Dr. Delese Mimi Darko

CEO-Food and Drugs Authority
Accra - Ghana

Dr. Jean-Francois Dierick
Dr. Jean-Francois Dierick

GSK Vaccines
Belgium

Gautam Sanyal
Gautam Sanyal

Principal Consultant
Vaccine Analytics, LLC
USA

Dr. Claudia Magagnoli
Dr. Claudia Magagnoli

Head-Analytical R&D
GSK Vaccines
Belgium

Invited Speakers

Prof.Thomas R. Fuerst
Prof.Thomas R. Fuerst

University of Maryland
USA

Claudia  Alvarez Zuniga
Claudia Alvarez Zuniga

Autonomous University of
Zacatecas
Mexico

Prof. Alejandro de la Pena-Moctezuma
Prof. Alejandro de la Pena-Moctezuma

National Autonomous University of Mexico-Mexico

Atef Fawaz
Atef Fawaz

E Health Africa
Nigeria

Dr. Ellie Abdi
Dr. Ellie Abdi

Montclair State University
USA

Loveth Metiboba
Loveth Metiboba

E Health Africa
Nigeria

Prof. Olivier Sparagano
Prof. Olivier Sparagano

City University of Hong Kong
Hong Kong

Prof. Robert Millar
Prof. Robert Millar

Director-Centre for Neuroendocrinology
UK

Dr. Phu Nguyen
Dr. Phu Nguyen

GSK Vaccines
Belgium

Dr. Xingmin Sun
Dr. Xingmin Sun

University of South Florida
USA

Maxime Vermeulen
Maxime Vermeulen

Scientist-Sciensano
Belgium

CARMEN TERESA CELIS GIRALDO
CARMEN TERESA CELIS GIRALDO

University of Applied and Environmental Sciences UDCA-Bogota-Colombia

Dr. Shahjahan Shaid
Dr. Shahjahan Shaid

GSK Vaccines
Belgium

Dr. James W. Hodge
Dr. James W. Hodge

Head-Recombinant Vaccine Group
NCI, NIH
USA

Kathleen L. Hefferon
Kathleen L. Hefferon

Cornell University
New York

Dr. H.M.Sampath Kumar
Dr. H.M.Sampath Kumar

Senior Principal Scientist
Indian Institute of Chemical Technology-India

Scientific Sessions
  • Covid -19 Vaccine Research and Development
  • Vaccines Against Drugs
  • Immunology of Infectious Diseases
  • Cancer, Malaria and TB Vaccines
  • Vaccine Regulation ,Safety and Efficacy
  • Hepatitis Vaccines and Liver Diseases
  • New Trends in Vaccines Development
  • RDT in Antibiotic Research
  • Vaccines Against Neurological Infections
  • Veterinary Vaccinology
  • Vaccine Durability (Measles, Mumps, Pertussis)
  • Alzheimer Vaccine
  • Nano Vaccine Technology
  • Plant Vaccines
  • Next Generation Vaccines Delivery Technologies
  • Vaccines For Older Adults
Scientific Sessions
  • DNA Vaccines
  • HIV/AIDS Vaccines
  • Travel and Edible Vaccines
  • Animal and Plant Derived Vaccines
  • Antibodies : Engineering and Therapeutics
  • Vaccine Storage and Handlings
  • Vaccines Misperception and Side Effects
  • Vaccines For Zector-Borne Diseases
  • Geriatric Immunization
  • Clinical Research and Clinical Trails
  • Live-Attenuates Vaccines
  • Importance of Vaccination
  • Vaccines for Pregnant Women and Neonates
  • Analytical Method Life Cycle, Analytical QbD and Vaccines release testing
  • Others

Need help now? Mail us now: vaccines-2021@pagesconferences.com

Book your Speaker or Delegate slot. Contact us regarding group registrations on special prices